ArticleAnnals of hematology2026

Optimizing venetoclax duration with hypomethylating agents for newly diagnosed acute myeloid leukemia: impact on response and survival.

Anush A Ginosyan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.